Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
Dimos D MitsikostasAndrzej DekundyAngelika HanschmannMichael AlthausAstrid ScheschonkaFernando PaganAbhishek LenkaPublished in: Current medical research and opinion (2021)
Subjects reported an effect onset from 5 days after injection lasting up to 20 weeks (maximum observation period). Data indicate that incobotulinumtoxinA re-treatment of blepharospasm may not be required at fixed 12-week intervals and provide evidence for a patient-tailored approach.